drugset
drugset / Trial / NCT02289235

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

NCT02289235 ↗

Phase 0 Completed 76 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators want to evaluate the effects and safety of ginger in treatment of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).

Timeline

Start
2019-05-01
Primary completion
2020-01-01
Completion
2020-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginger Traditional medicine (herbal / TCM) 1000 mg —

Indications

fatty liver disease type 2 diabetes mellitus